影响IIA期结肠癌患者复发和生存的因素
Mert Erciyestepe1, Oğuzhan Selvi1, Gülhan Dinç1
1Department of Medical Oncology, Sağlık Bilimleri University, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey.
Oncology
|July 15, 2024
概括
辅助治疗对于IIA期结肠癌患者具有多种风险因素至关重要,显著改善无病生存率 (DFS). 然而,在某些情况下,capecitabine的使用与更高的复发率有关.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 第IIA期结肠癌 (T3N0M0) 在复发和生存方面存在复杂的挑战.
- 确定关键的风险因素和优化辅助治疗对于患者的治疗结果至关重要.
研究的目的:
- 研究风险因素和辅助治疗对IIA期结肠癌复发和生存的影响.
- 分析不同辅助疗法的有效性,与患者的风险概况相关.
主要方法:
- 对220名IIA期结肠癌患者的病历进行了回顾性分析.
- 评估人口统计数据,瘤特征,微卫星不稳定性,CEA水平和辅助治疗.
- 基于风险因素和接受的治疗,评估无病生存期 (DFS).
主要成果:
- 患有多个危险因素的患者与患有单个危险因素的患者相比,DFS显著降低 (p=0.017).
- 在患有多种风险因素的患者中,辅助治疗显著改善了DFS (p<0.001).
- 在经历了复发的患者中,capecitabine的使用与更高的复发率有关 (p=0.01).
结论:
- 对IIA期结肠癌的辅助化疗决定需要仔细考虑个体风险因素.
- 需要进一步的研究来完善治疗建议,尽量减少毒性,优化患者的治疗结果.
相关概念视频
Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Actuarial Approach
73
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
73
Assumptions of Survival Analysis
121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


